TOPLINE: A nonsurgical combination treatment for keloids achieved complete resolution in over 80% of patients and was associated with high satisfaction rates in an observational study […]

TOPLINE: In a multicentre cross-sectional study, the majority of patients with solar urticaria were of European ethnicity, with Fitzpatrick skin phototypes I-III; urticaria provocation was achieved […]

TOPLINE: Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. […]

TOPLINE: In a large cohort study, each additional blistering sunburn before the age of 15 years increased melanoma risk by approximately 3%, and the associated risk […]

TOPLINE: Hormonal intrauterine devices (IUDs), unlike oral contraceptives, were not linked with an increased risk for melasma in women with menorrhagia, this study found. METHODOLOGY: Researchers […]

TOPLINE:  In a large US cohort study, patients with primary cutaneous B-cell lymphoma (pCBCL) had significantly higher risks of developing hematologic and prostate cancers. METHODOLOGY: Researchers […]

TOPLINE: Ivarmacitinib, a selective oral Janus kinase 1 inhibitor, significantly improved signs and symptoms in patients with moderate to severe atopic dermatitis (AD) and showed a […]